Form 8-K - Current report:
SEC Accession No. 0001640334-19-000168
Filing Date
2019-02-06
Accepted
2019-02-06 16:38:06
Documents
2
Period of Report
2019-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K inmune_8k.htm 8-K 17941
2 EX-99.1 inmune_ex991.htm EX-99.1 7914
  Complete submission text file 0001640334-19-000168.txt   27042
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 19571989
SIC: 2836 Biological Products, (No Diagnostic Substances)